mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
5e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
7e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |